Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials (Q49167189)
scientific article published on July 9, 2014
Language:
Current Data About Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
(P31) (Q13442814)
(P248)
(P698) 25007392
(P813) Sunday, February 18, 2018
(P854) http://europepmc.org/abstract/MED/25007392

(P50) (Q49167237)
(P1932) Bárður Sigurgeirsson
(P1545) 10

(Q57163552)
(P1932) Tsen-Fang Tsai
(P1545) 12

(Q6767705)
(P1545) 3
(P1932) Mark Lebwohl
(P248)
(P698) 25007392
(P813) Sunday, February 18, 2018
(P854) http://europepmc.org/abstract/MED/25007392

(P304) 326-338
(P248)
(P698) 25007392
(P813) Sunday, February 18, 2018
(P854) http://europepmc.org/abstract/MED/25007392

(P407) (Q1860)

(P433) 4
(P248)
(P698) 25007392
(P813) Sunday, February 18, 2018
(P854) http://europepmc.org/abstract/MED/25007392

(P478) 371
(P248)
(P698) 25007392
(P813) Sunday, February 18, 2018
(P854) http://europepmc.org/abstract/MED/25007392

(P577) Wednesday, July 9, 2014
(P248)
(P698) 25007392
(P813) Sunday, February 18, 2018
(P854) http://europepmc.org/abstract/MED/25007392

(P921) (Q42824827)

(Q7444755)

(P953) https://doi.org/10.1056/nejmoa1314258
(P6954)
(P248)
(P698) 25007392
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A25007392
(P813) Friday, June 20, 2025

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1314258
(P248)
(P356) 10.1056/NEJMOA1314258
(P854) https://api.crossref.org/works/10.1056/NEJMOA1314258
(P813) Friday, June 20, 2025

(P1433) (Q582728)
(P248)
(P698) 25007392
(P813) Sunday, February 18, 2018
(P854) http://europepmc.org/abstract/MED/25007392

(P1476) "Secukinumab in plaque psoriasis--results of two phase 3 trials" (language: en)
(P248)
(P698) 25007392
(P813) Sunday, February 18, 2018
(P854) http://europepmc.org/abstract/MED/25007392

"Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials" (language: en)
(P248)
(P356) 10.1056/NEJMOA1314258
(P854) https://api.crossref.org/works/10.1056/NEJMOA1314258
(P813) Friday, June 20, 2025

(P2093) Kristian Reich
(P1545) 4
(P248)
(P698) 25007392
(P813) Sunday, February 18, 2018
(P854) http://europepmc.org/abstract/MED/25007392

Kim Papp
(P1545) 6
(P248)
(P698) 25007392
(P813) Sunday, February 18, 2018
(P854) http://europepmc.org/abstract/MED/25007392

Lluís Puig
(P1545) 7
(P248)
(P698) 25007392
(P813) Sunday, February 18, 2018
(P854) http://europepmc.org/abstract/MED/25007392

Hidemi Nakagawa
(P1545) 8
(P248)
(P698) 25007392
(P813) Sunday, February 18, 2018
(P854) http://europepmc.org/abstract/MED/25007392

Lynda Spelman
(P1545) 9
(P248)
(P698) 25007392
(P813) Sunday, February 18, 2018
(P854) http://europepmc.org/abstract/MED/25007392

Enrique Rivas
(P1545) 11
(P248)
(P698) 25007392
(P813) Sunday, February 18, 2018
(P854) http://europepmc.org/abstract/MED/25007392

Norman Wasel
(P1545) 13
(P248)
(P698) 25007392
(P813) Sunday, February 18, 2018
(P854) http://europepmc.org/abstract/MED/25007392

Stephen Tyring
(P1545) 14
(P248)
(P698) 25007392
(P813) Sunday, February 18, 2018
(P854) http://europepmc.org/abstract/MED/25007392

Thomas Salko
(P1545) 15
(P248)
(P698) 25007392
(P813) Sunday, February 18, 2018
(P854) http://europepmc.org/abstract/MED/25007392

Isabelle Hampele
(P1545) 16
(P248)
(P698) 25007392
(P813) Sunday, February 18, 2018
(P854) http://europepmc.org/abstract/MED/25007392

Marianne Notter
(P1545) 17
(P248)
(P698) 25007392
(P813) Sunday, February 18, 2018
(P854) http://europepmc.org/abstract/MED/25007392

Alexander Karpov
(P1545) 18
(P248)
(P698) 25007392
(P813) Sunday, February 18, 2018
(P854) http://europepmc.org/abstract/MED/25007392

Silvia Helou
(P1545) 19
(P248)
(P698) 25007392
(P813) Sunday, February 18, 2018
(P854) http://europepmc.org/abstract/MED/25007392

Charis Papavassilis
(P1545) 20
(P248)
(P698) 25007392
(P813) Sunday, February 18, 2018
(P854) http://europepmc.org/abstract/MED/25007392

ERASURE Study Group
(P1545) 21
(P248)
(P698) 25007392
(P813) Sunday, February 18, 2018
(P854) http://europepmc.org/abstract/MED/25007392

FIXTURE Study Group
(P1545) 22
(P248)
(P698) 25007392
(P813) Sunday, February 18, 2018
(P854) http://europepmc.org/abstract/MED/25007392

Richard G. Langley
(P1545) 1
(P248)
(P698) 25007392
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A25007392
(P813) Friday, June 20, 2025

Boni E. Elewski
(P1545) 2
(P248)
(P698) 25007392
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A25007392
(P813) Friday, June 20, 2025

Mark Lebwohl
(P1545) 3
(P248)
(P698) 25007392
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A25007392
(P813) Friday, June 20, 2025

Christopher E. M. Griffiths
(P1545) 5
(P248)
(P698) 25007392
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A25007392
(P813) Friday, June 20, 2025

other details
description scientific article published on July 9, 2014

External Links
(P356) 10.1056/NEJMOA1314258
(P698) 25007392